title: Highlights from the 2013 Science of Placebo thematic workshop.
abstract: In the last 30 years, a converging series of laboratory experiments, clinical trials, and neurocognitive studies have identified several key mechanisms of placebo effects. These studies suggest not only that placebo responses may be ubiquitous across research and clinical settings, but also that they can significantly modulate symptoms across a wide spectrum of highly prevalent conditions such as acute pain, chronic pain, anxiety, depression, Parkinson's disease, and nausea, just to name a few. In order to inform the medical community about the most recent advances in the field of placebo studies, a thematic workshop entitled "The Science of Placebo" was held at the Beth Israel Deaconesses Medical Center (BIDMC), Harvard Medical School, in Boston (MA), on the 19-20 of June 2013. The workshop, sponsored by The Robert Wood Johnson Foundation, was organised by the Program in Placebo Studies and the Therapeutic Encounter, a Harvard-wide network of researchers dedicated to the study of the placebo phenomenon hosted by the BIDMC. The event was structured as a series of four public lectures, each delivered by a leading investigator in the field of placebo studies. The four keynote speakers were Fabrizio Benedetti, professor of neurophysiology and human physiology at the University of Turin Medical School and at the National Institute of Neuroscience in Italy; Tor Wager, director of the Cognitive and Affective Control Laboratory and associate professor of psychology and neuroscience at the University of Colorado; Predrag Petrovic, psychiatrist and researcher in the Department of Clinical Neuroscience at the Karolinska Institute in Stockholm; and Ted Kaptchuk, director of the Program in Placebo Studies and associate professor of medicine at Harvard Medical School.
authors.affiliation: University of Milan, Department of Health Sciences, Milan 20142, Italy.
authors.forename: Marco
authors.initials: M
authors.lastname: Annoni
keywords: PET; Parkinson; acupuncture; chronic pain; clinical trial; depression; fMRI; pain; placebo; placebo effect; placebo response; randomisation
references.citation: Nat Neurosci. 2005 Sep;8(9):1234-40
references.pmid: 16116445
references.citation: N Engl J Med. 2011 Jul 14;365(2):119-26
references.pmid: 21751905
references.citation: Lancet Neurol. 2004 Nov;3(11):679-84
references.pmid: 15488461
references.citation: Neuron. 2005 Sep 1;47(5):633-6
references.pmid: 16129393
references.citation: PLoS One. 2010 Dec 22;5(12):e15591
references.pmid: 21203519
references.citation: Science. 2004 Feb 20;303(5661):1162-7
references.pmid: 14976306
references.citation: Science. 2002 Mar 1;295(5560):1737-40
references.pmid: 11834781
references.citation: BMJ. 2008 May 3;336(7651):999-1003
references.pmid: 18390493
references.citation: Arch Intern Med. 2007 Sep 24;167(17):1892-8
references.pmid: 17893311
references.citation: Lancet. 1978 Sep 23;2(8091):654-7
references.pmid: 80579
references.citation: PLoS Med. 2008 Feb;5(2):e45
references.pmid: 18303940
references.citation: Neuron. 2005 Jun 16;46(6):957-69
references.pmid: 15953423
references.citation: Trends Cogn Sci. 2012 Mar;16(3):147-56
references.pmid: 22310704
references.citation: Nat Neurosci. 2004 Jun;7(6):587-8
references.pmid: 15146189
references.citation: J Neurosci. 1999 Jan 1;19(1):484-94
references.pmid: 9870976
references.citation: J Neurosci. 2011 Nov 9;31(45):16117-24
references.pmid: 22072664
references.citation: Psychol Sci. 2012 Mar;23(3):246-53
references.pmid: 22261568
references.citation: J Physiol. 2009 Aug 1;587(Pt 15):3869-83
references.pmid: 19546163